Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastases
Abstract Background Despite recent advancements in metastatic melanoma treatment, the emergence of melanoma brain metastases (MBM) continues to pose a challenge. This study aimed to explore factors associated with MBM development. Methods This retrospective study included patients diagnosed with adv...
Gorde:
| Egile Nagusiak: | , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Nature Portfolio
2025-04-01
|
| Saila: | BJC Reports |
| Sarrera elektronikoa: | https://doi.org/10.1038/s44276-025-00137-2 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|